abstract |
The present invention is directed to N- (2- (cyclic amine) ethyl) benzamide derivatives of the formula (I), as p2x7 inhibitors, pharmaceutical compositions comprising the compounds and the uses of the compounds for treating pain, inflammation , neurological disorders or neuropsychiatric disorders (see Formula). |